SHARE

Roche to take stake in LumiraDx diagnostics platform

The Swiss drugmaker has announced that it will buy LumiraDx’s Point of Care diagnostics platform business for c.$295m. Founded in 2014, LumiraDx has been developing a diagnostic platform that supports a broad menu of tests at the point of care.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.